Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M BERGMAN

Showing results (691-700 of 784) with videos related to

Pageof 79
Sort By:
Endoscopy|February 13, 2025
Outcomes after radical endoscopic resection of high risk T1 esophageal adenocarcinoma: an international multicenter retrospective cohort studyMan Wai Chan, Rehan Haidry, Benjamin Norton, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|June 7, 2018
The Amsterdam ReBus progressor cohort: identification of 165 Barrett's surveillance patients who progressed to early neoplasia and 723 nonprogressor patientsL C Duits, E Klaver, A Bureo Gonzalez, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2016
A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's EsophagusRebecca J Critchley-Thorne, Jon M Davison, Jeffrey W Prichard, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 28, 2011
Accuracy and reproducibility of 3D-CT measurements for early response assessment of chemoradiotherapy in patients with oesophageal cancerM van Heijl, S S K S Phoa, M I van Berge Henegouwen, et al.
Gut|March 4, 2015
Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II)K Nadine Phoa, Roos E Pouw, Raf Bisschops, et al.
Endoscopy|February 20, 2024
Vertical tumor-positive resection margins and the risk of residual neoplasia after endoscopic resection of Barrett's neoplasia: a nationwide cohort with pathology reassessmentLaurelle van Tilburg, Eva P D Verheij, Steffi E M van de Ven, et al.
Prostate Cancer and Prostatic Diseases|October 12, 2022
Incidence and survival of castration-resistant prostate cancer patients with visceral metastases: results from the Dutch CAPRI-registryGijs P A van den Bergh, Malou C P Kuppen, Hans M Westgeest, et al.
Oncology|August 22, 2016
Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate CancerSushil K Badrising, Vincent van der Noort, Paul Hamberg, et al.
Gastroenterology|December 26, 2016
Patients With Barrett's Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to NeoplasiaLucas C Duits, Myrtle J van der Wel, Cary C Cotton, et al.
Frontiers in Oncology|November 4, 2022
Team dynamics and clinician's experience influence decision-making during Upper-GI multidisciplinary team meetings: A multiple case studyJ C H B M Luijten, M J Westerman, G A P Nieuwenhuijzen, et al.
Pageof 79

Showing results (691-700 of 784) with videos related to

Sort By:
Pageof 79
Endoscopy|February 13, 2025
Outcomes after radical endoscopic resection of high risk T1 esophageal adenocarcinoma: an international multicenter retrospective cohort studyMan Wai Chan, Rehan Haidry, Benjamin Norton, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|June 7, 2018
The Amsterdam ReBus progressor cohort: identification of 165 Barrett's surveillance patients who progressed to early neoplasia and 723 nonprogressor patientsL C Duits, E Klaver, A Bureo Gonzalez, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2016
A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's EsophagusRebecca J Critchley-Thorne, Jon M Davison, Jeffrey W Prichard, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 28, 2011
Accuracy and reproducibility of 3D-CT measurements for early response assessment of chemoradiotherapy in patients with oesophageal cancerM van Heijl, S S K S Phoa, M I van Berge Henegouwen, et al.
Gut|March 4, 2015
Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II)K Nadine Phoa, Roos E Pouw, Raf Bisschops, et al.
Endoscopy|February 20, 2024
Vertical tumor-positive resection margins and the risk of residual neoplasia after endoscopic resection of Barrett's neoplasia: a nationwide cohort with pathology reassessmentLaurelle van Tilburg, Eva P D Verheij, Steffi E M van de Ven, et al.
Prostate Cancer and Prostatic Diseases|October 12, 2022
Incidence and survival of castration-resistant prostate cancer patients with visceral metastases: results from the Dutch CAPRI-registryGijs P A van den Bergh, Malou C P Kuppen, Hans M Westgeest, et al.
Oncology|August 22, 2016
Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate CancerSushil K Badrising, Vincent van der Noort, Paul Hamberg, et al.
Gastroenterology|December 26, 2016
Patients With Barrett's Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to NeoplasiaLucas C Duits, Myrtle J van der Wel, Cary C Cotton, et al.
Frontiers in Oncology|November 4, 2022
Team dynamics and clinician's experience influence decision-making during Upper-GI multidisciplinary team meetings: A multiple case studyJ C H B M Luijten, M J Westerman, G A P Nieuwenhuijzen, et al.
Pageof 79